Close Menu

Beckman Coulter

BioArray Briefs: 2009.04.07

Premium

CGC Genetics, Nuvera Biosciences, Veridex, ImaGenes, CapitalBio, Fisher Healthcare, Osmetech, National Institutes of Health, Clinical Data, Cogenics, UK Biotechnology and Biological Sciences Research Council

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

Cogenics' services will complement those already offered by Beckman Coulter's Agencourt Biosciences business.

Short Reads: Mar 31, 2009

Premium

Helicos, Agencourt, Illumina, RainDance Technologies, Ontario Institute for Cancer Research, VWR International, ZyGem, University of Queensland, University of Michigan, Genomatix

Beckman said the closing payment for the deal would fixed at $780 million. It also said that it would eliminate Olympus' immunoassay product line and related R&D efforts after the closing of the deal.

The $800 million acquisition will strengthen Beckman Coulter's presence in the clinical chemistry market. The firm does not anticipate a change in its current investment grade ratings due to the new debt.

IP Roundup: Feb 24, 2009

Premium

CalTech, Beckman Coulter, Genisphere, Seiko Epson

Included is a paper on the use of a mass spectrometry-based strategy for the absolute quantification of protein complex components, one using SISCAPA technology, and one showing that top-down proteomics can be done using CID on a q-TOF instrument.

News Scan: Feb 13, 2009

Premium

Trevena, Ligand Pharmaceuticals, Ibidi, Seahorse Bioscience

Regardless of the outcome of the first phase of the trial, Life Technologies declared victory last week, saying that the patents are irrelevant for current or future versions of the SOLiD technology.

Pages

CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.